PCFM Lab, GD HPPC Lab, School of Chemistry, Sun Yat-sen University, Guangzhou, China.
Guangdong Functional Biomaterials Engineering Technology Research Center, School of Materials Science and Engineering, Sun Yat-sen University, Guangzhou, China.
Tissue Eng Part A. 2021 Jun;27(11-12):771-787. doi: 10.1089/ten.TEA.2020.0227. Epub 2020 Nov 20.
Neurological functional recovery depends on the synergistic interaction between angiogenesis and neurogenesis after peripheral nerve injury (PNI). Decellularized nerve matrix hydrogels have drawn much attention and been considered as potential therapeutic biomaterials for neurovascularization, due to their intrinsic advantages in construction of a growth-permissive microenvironment, strong affinity to multiple growth factors (GFs), and promotion of neurite outgrowth. In the present study, nerve growth factor (NGF) and vascular endothelial growth factor (VEGF) were incorporated into porcine decellularized nerve matrix hydrogel (pDNM-gel) for PNI treatment. Both GFs bound strongly to pDNM-gel and underwent a controlled release manner, which showed facilitated axonal extension and vascular-like tube formation . Especially, a companion growth was identified when human umbilical vein endothelial cells and neurons were cocultured on the GFs containing pDNM-gel. In a crushed rat sciatic nerve model, the incorporated NGF and VEGF appeared to contribute for axonal growth and neovascularization correspondingly but separately. Both GFs were equally important in improving nerve functional recovery after administration. These findings indicate that pDNM-gel is not only a bioactive hydrogel-based material that can be used alone, but also serves as suitable carrier of multiple GFs for promoting an effective PNI repair. Impact statement Decellularized matrix hydrogel derived from nerve tissue has demonstrated its effectiveness in promoting nerve reinnervation, remyelination, and functionalization. Meanwhile, angiogenesis is highly desirable for treatment of long-distance peripheral nerve defects. To this end, we incorporated both vascular endothelial growth factor (VEGF) and nerve growth factor (NGF) into porcine decellularized nerve matrix hydrogel (pDNM-gel) to induce neovascularization and neuroregeneration. At the cellular level, the pDNM-gel with both growth factors (GFs) exhibited significant capability in promoting axonal elongation, Schwann cell proliferation and migration, as well as vessel/nerve interaction. In crushed peripheral nerve injury (PNI) rat model, the integrated VEGF was more favorable for angiogenesis, whereas NGF mainly contributed to neurogenesis. However, the combination of both GFs in pDNM-gel highly facilitated motor functional recovery, highlighting the therapeutic promise of decellularized matrix hydrogel for growth factor delivery toward neuroprotection and neuroregeneration after PNI.
神经功能的恢复取决于周围神经损伤 (PNI) 后血管生成和神经发生的协同相互作用。脱细胞神经基质水凝胶因其在构建有利于生长的微环境、与多种生长因子 (GFs) 具有强亲和力以及促进神经突生长方面的固有优势,而受到广泛关注,并被认为是神经血管化的潜在治疗生物材料。在本研究中,将神经生长因子 (NGF) 和血管内皮生长因子 (VEGF) 掺入猪脱细胞神经基质水凝胶 (pDNM-gel) 中用于 PNI 治疗。两种 GFs 均与 pDNM-gel 紧密结合,并以受控方式释放,这促进了轴突的延伸和类似血管的管腔形成。特别是,当人脐静脉内皮细胞和神经元在含有 GFs 的 pDNM-gel 上共培养时,鉴定出一种伴随生长。在大鼠坐骨神经挤压模型中,掺入的 NGF 和 VEGF 似乎分别对应地但独立地促进轴突生长和新生血管形成。两种 GFs 在给药后改善神经功能恢复方面同样重要。这些发现表明,pDNM-gel 不仅是一种可单独使用的生物活性水凝胶基材料,而且还可以作为多种 GFs 的合适载体,以促进有效的 PNI 修复。